Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mulholland, Paul
NeAT Glio, NCT05074992: A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma	Terminated	2	1	Europe	Ipilimumab	University College, London, Bristol-Myers Squibb	Glioblastoma	05/23	05/23
CITADEL-123, NCT06650605: Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma	Recruiting	1	67	Europe	123I-ATT001	Theragnostics Ltd	Glioma Glioblastoma Multiforme	12/26	04/27
NCT03423628: A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer Jan 2024 - Dec 2024: Data from trial in combination with radiation therapy for brain metastases	Recruiting	1	180	Europe, Japan, US	Radiation Therapy, Radiotherapy, Radiation treatment, RT, AZD1390, ATM inhibitor	AstraZeneca	Recurrent Glioblastoma Multiforme, Primary Glioblastoma Multiforme, Brain Neoplasms, Malignant, Leptomeningeal Disease (LMD)	09/26	09/26